Skip to main
University-wide Navigation

‘Behind the Blue’: Advancing clinical research with CCTS Director Katherine Hartmann

In this episode of " Behind the Blue", Katherine Hartmann, the new director of UK's Center for Clinical and Translational Science, discusses her research in women's health, the impetus behind translational research and science, and UK's unique position to move the work of our researchers from campus to our community.

UK Begins 1st Clinical Trial in the World for Newly Discovered Form of Dementia

The world’s first clinical trial for a form of dementia identified in 2019 is officially underway by researchers at the University of Kentucky's Sanders-Brown Center on Aging.

Parents are 'Proud Our Daughters are Doing Their Part' in Vaccine Research Trial

Professor Stacy Stanifer enrolled her three daughters in the Moderna KidCOVE clinical trial to test the dosage and efficacy of the COVID-19 vaccine in children ages 6 months through 11 years old.

'Behind the Blue': Philip A. Kern Discusses UK’s Center for Clinical and Translational Science

On this episode of "Behind the Blue," CCTS Director Philip A. Kern, M.D., talks about the vast amount of work the center supports.

Results of Johnson & Johnson COVID-19 Vaccine Trial Announced

The Phase 3 randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen investigational COVID-19 vaccine candidate versus placebo. Approximately 45,000 people participated worldwide. The combined UK, Baptist and Norton site was among the top enrolling sites in the world.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

'Behind the Blue': Dr. Peter Nelson Discusses UK’s Leading Efforts on Alzheimer’s and Dementia Research

Dr. Peter Nelson, of the UK Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease.

UK and Baptist Health Lexington, Norton Health Care Begin Recruiting Participants for Phase 3 COVID-19 Investigational Vaccine Clinical Trial

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Health Sciences Team Leading $2.5 Million Multi-Site Ankle Injury Research Project

A team of Health Sciences investigators are collaborating with military researchers at the Naval Health Research Center and faculty at the University of Virginia to find rehabilitative solutions for populations most at risk for chronic and future ankle injuries.

Filter News